Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.

Kapica-Topczewska K, Tarasiuk J, Collin F, Brola W, Chorąży M, Czarnowska A, Kwaśniewski M, Bartosik-Psujek H, Adamczyk-Sowa M, Kochanowicz J, Kułakowska A.

PLoS One. 2019 Oct 24;14(10):e0223863. doi: 10.1371/journal.pone.0223863. eCollection 2019.

2.

Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas.

Lesluyes T, Baud J, Pérot G, Charon-Barra C, You A, Valo I, Bazille C, Mishellany F, Leroux A, Renard-Oldrini S, Terrier P, Le Cesne A, Laé M, Piperno-Neumann S, Bonvalot S, Neuville A, Collin F, Maingon P, Coindre JM, Chibon F.

Mod Pathol. 2019 Jun 26. doi: 10.1038/s41379-019-0300-2. [Epub ahead of print]

PMID:
31243333
3.

The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.

Collin F, Maxwell A.

J Mol Biol. 2019 Aug 23;431(18):3400-3426. doi: 10.1016/j.jmb.2019.05.050. Epub 2019 Jun 8. Review.

4.

Capillary electrophoresis/visible-LED induced fluorescence of tryptophan: What's new?

Perquis L, Ta HY, Ong-Meang V, Poinso A, Collin F, Poinsot V, Couderc F.

Electrophoresis. 2019 Sep;40(18-19):2342-2348. doi: 10.1002/elps.201900058. Epub 2019 Jul 2.

PMID:
31162686
5.

Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases.

Collin F.

Int J Mol Sci. 2019 May 15;20(10). pii: E2407. doi: 10.3390/ijms20102407. Review.

6.

Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.

Samri A, Charpentier C, Diallo MS, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, Brun-Vézinet F, Autran B; ANRS CO5 IMMUNOVIR-2 Study Group.

PLoS Pathog. 2019 May 16;15(5):e1007758. doi: 10.1371/journal.ppat.1007758. eCollection 2019 May.

7.

Feasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field Trial.

Hooper E, Simkin Z, Abrams H, Camacho E, Charalambous AP, Collin F, Constantinidou F, Dawes P, Elliott R, Falkingham S, Frison E, Hann M, Helmer C, Himmelsbach I, Hussain H, Marié S, Montecelo S, Reeves D, Regan J, Thodi C, Wolski L, Leroi I.

J Am Geriatr Soc. 2019 Jul;67(7):1472-1477. doi: 10.1111/jgs.15936. Epub 2019 Apr 29.

PMID:
31034588
8.

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

Mirjolet C, Merlin JL, Truc G, Noël G, Thariat J, Domont J, Sargos P, Renard-Oldrini S, Ray-Coquard I, Liem X, Chevreau C, Lagrange JL, Mahé MA, Collin F, Bonnetain F, Bertaut A, Maingon P.

EBioMedicine. 2019 Mar;41:420-426. doi: 10.1016/j.ebiom.2019.02.031. Epub 2019 Mar 1.

9.

Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial.

Regan J, Frison E, Collin F, Dawes P, Hann M, Himmelsbach I, Hooper E, Reeves D, Simkin Z, Thodi C, Yang F, Leroi I; SENSE-Cog Trial Development Team.

Trials. 2019 Jan 25;20(1):80. doi: 10.1186/s13063-018-2973-0.

10.

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain.

Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C; ANRS CO5 HIV-2 Cohort.

Clin Infect Dis. 2018 Nov 1. doi: 10.1093/cid/ciy940. [Epub ahead of print]

PMID:
30383215
11.

Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses.

Iyer SS, Gensollen T, Gandhi A, Oh SF, Neves JF, Collin F, Lavin R, Serra C, Glickman J, de Silva PSA, Sartor RB, Besra G, Hauser R, Maxwell A, Llebaria A, Blumberg RS.

Cell. 2018 May 17;173(5):1123-1134.e11. doi: 10.1016/j.cell.2018.04.037.

12.

Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.

Italiano A, Touati N, Litière S, Collin F, Pourquier P, Gronchi A.

Cancer Med. 2018 May;7(5):1575-1577. doi: 10.1002/cam4.1403. Epub 2018 Apr 15.

13.

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).

Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group.

Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.

14.

Oxidative stress as a biomarker for Alzheimer's disease.

Collin F, Cheignon C, Hureau C.

Biomark Med. 2018 Mar;12(3):201-203. doi: 10.2217/bmm-2017-0456. Epub 2018 Feb 13. No abstract available.

15.

Tuning the MnII2/MnIII2 redox cycle of a phenoxo-bridged diMn catalase mimic with terminal carboxylate donors.

Solís V, Palopoli C, Daier V, Rivière E, Collin F, Moreno DM, Hureau C, Signorella S.

J Inorg Biochem. 2018 May;182:29-36. doi: 10.1016/j.jinorgbio.2018.01.013. Epub 2018 Feb 2.

PMID:
29407867
16.

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

Penel N, Coindre JM, Giraud A, Terrier P, Ranchere-Vince D, Collin F, Guellec SLE, Bazille C, Lae M, de Pinieux G, Ray-Coquard IL, Bonvalot S, Cesne ALE, Robin YM, Stoeckle E, Toulmonde M, Blay JY.

Cancer. 2018 Mar 15;124(6):1179-1187. doi: 10.1002/cncr.31176. Epub 2017 Dec 6.

17.

Oxidative stress and the amyloid beta peptide in Alzheimer's disease.

Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F.

Redox Biol. 2018 Apr;14:450-464. doi: 10.1016/j.redox.2017.10.014. Epub 2017 Oct 18. Review.

18.

Identification of key structural features of the elusive Cu-Aβ complex that generates ROS in Alzheimer's disease.

Cheignon C, Jones M, Atrián-Blasco E, Kieffer I, Faller P, Collin F, Hureau C.

Chem Sci. 2017 Jul 1;8(7):5107-5118. doi: 10.1039/c7sc00809k. Epub 2017 May 4.

19.

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V.

J Clin Microbiol. 2017 Sep;55(9):2850-2857. doi: 10.1128/JCM.00755-17. Epub 2017 Jul 12.

20.

Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.

Young RJ, Litière S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F, Messiou C, Grünwald V, Gronchi A, van der Graaf W, Wardelmann E, Judson I.

Acta Oncol. 2017 Jul;56(7):1013-1020. doi: 10.1080/0284186X.2017.1315173. Epub 2017 Apr 21.

21.

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

Bertucci F, Finetti P, Perrot D, Leroux A, Collin F, Le Cesne A, Coindre JM, Blay JY, Birnbaum D, Mamessier E.

Oncoimmunology. 2017 Feb 8;6(3):e1278100. doi: 10.1080/2162402X.2016.1278100. eCollection 2017.

22.

Thermochemistry and kinetics of graphite oxide exothermic decomposition for safety in large-scale storage and processing.

Qiu Y, Collin F, Hurt RH, Külaots I.

Carbon N Y. 2016 Jan;96:20-28. doi: 10.1016/j.carbon.2015.09.040. Epub 2015 Sep 11.

23.

Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production.

Cheignon C, Faller P, Testemale D, Hureau C, Collin F.

Metallomics. 2016 Oct 1;8(10):1081-1089.

24.

Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides.

Alies B, Conte-Daban A, Sayen S, Collin F, Kieffer I, Guillon E, Faller P, Hureau C.

Inorg Chem. 2016 Oct 17;55(20):10499-10509. Epub 2016 Sep 26.

25.

[Sarcoma developed in irradiated area: Preliminary results of the SARI trial].

Maingon P, Mirjolet C, Diallo I, Veres C, Collin F, Italiano A, Chibon F, Merlin JL, Coindre JM.

Cancer Radiother. 2016 Oct;20(6-7):690-3. doi: 10.1016/j.canrad.2016.07.071. Epub 2016 Sep 3. French.

PMID:
27599685
26.

Prevalence and factors associated with discordant intima-media thickness and arterial stiffness combined measurements in people living with HIV.

Jean M, Saada M, Collin F, Roustant F, Aumaître H.

Infect Dis (Lond). 2016 Nov-Dec;48(11-12):857-9. doi: 10.1080/23744235.2016.1201854. Epub 2016 Jul 8. No abstract available.

PMID:
27386739
27.

Is ascorbate Dr Jekyll or Mr Hyde in the Cu(Aβ) mediated oxidative stress linked to Alzheimer's disease?

Cheignon C, Collin F, Faller P, Hureau C.

Dalton Trans. 2016 Aug 9;45(32):12627-31. doi: 10.1039/c6dt01979j.

28.

A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm.

Khemissa F, Mineur L, Amsellem C, Assenat E, Ramdani M, Bachmann P, Janiszewski C, Cristiani I, Collin F, Courraud J, de Forges H, Dechelotte P, Senesse P.

Dig Liver Dis. 2016 Mar;48(3):327-32. doi: 10.1016/j.dld.2015.11.025. Epub 2015 Dec 15.

PMID:
26776879
29.

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting.

Wardelmann E, Haas RL, Bovée JV, Terrier P, Lazar A, Messiou C, LePechoux C, Hartmann W, Collin F, Fisher C, Mechtersheimer G, DeiTos AP, Stacchiotti S, Jones RL, Gronchi A, Bonvalot S.

Eur J Cancer. 2016 Jan;53:84-95. doi: 10.1016/j.ejca.2015.09.021. Epub 2015 Dec 14.

PMID:
26700077
30.

Shear wave elastography: An accurate technique to stage liver fibrosis in chronic liver diseases.

Guibal A, Renosi G, Rode A, Scoazec JY, Guillaud O, Chardon L, Munteanu M, Dumortier J, Collin F, Lefort T.

Diagn Interv Imaging. 2016 Jan;97(1):91-9. doi: 10.1016/j.diii.2015.11.001. Epub 2015 Dec 3.

31.

Free Superoxide is an Intermediate in the Production of H2O2 by Copper(I)-Aβ Peptide and O2.

Reybier K, Ayala S, Alies B, Rodrigues JV, Bustos Rodriguez S, La Penna G, Collin F, Gomes CM, Hureau C, Faller P.

Angew Chem Int Ed Engl. 2016 Jan 18;55(3):1085-9. doi: 10.1002/anie.201508597. Epub 2015 Dec 2.

PMID:
26629876
32.

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

Bui-Nguyen B, Butrynski JE, Penel N, Blay JY, Isambert N, Milhem M, Kerst JM, Reyners AK, Litière S, Marréaud S, Collin F, van der Graaf WT; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC/STBSG) and the Sarcoma Alliance for Research through Collaboration (SARC).

Eur J Cancer. 2015 Jul;51(10):1312-20. doi: 10.1016/j.ejca.2015.03.023. Epub 2015 Apr 23.

PMID:
25912752
33.

Lead selection and characterization of antitubercular compounds using the Nested Chemical Library.

Sipos A, Pató J, Székely R, Hartkoorn RC, Kékesi L, Őrfi L, Szántai-Kis C, Mikušová K, Svetlíková Z, Korduláková J, Nagaraja V, Godbole AA, Bush N, Collin F, Maxwell A, Cole ST, Kéri G.

Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S200-6. doi: 10.1016/j.tube.2015.02.028. Epub 2015 Feb 28.

PMID:
25801335
34.

[Intra-abdominal soft tissue tumors. What needs to be known to reach the diagnosis with the help of immunohistochemistry, FISH and molecular biology].

Collin F, de Saint Aubain N.

Ann Pathol. 2015 Jan;35(1):114-25. doi: 10.1016/j.annpat.2014.11.007. Epub 2014 Dec 23. Review. French.

PMID:
25541116
35.

Laboratory studies of carbon kinetic isotope effects on the production mechanism of particulate phenolic compounds formed by toluene photooxidation: a tool to constrain reaction pathways.

Irei S, Rudolph J, Huang L, Auld J, Collin F, Hastie D.

J Phys Chem A. 2015 Jan 8;119(1):5-13. doi: 10.1021/jp5104609. Epub 2014 Dec 26.

PMID:
25490235
36.

[Non-targeted effects (bystander, abscopal) of external beam radiation therapy: an overview for the clinician].

Sun R, Sbai A, Ganem G, Boudabous M, Collin F, Marcy PY, Doglio A, Thariat J.

Cancer Radiother. 2014 Dec;18(8):770-8. doi: 10.1016/j.canrad.2014.08.004. Epub 2014 Oct 14. Review. French.

PMID:
25451674
37.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin RS, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijfer S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S; Definition for the Assessment of Time-to-event Endpoints in Cancer Trials Initiative.

Ann Oncol. 2015 May;26(5):865-72. doi: 10.1093/annonc/mdu360. Epub 2014 Jul 28. Review.

38.

Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas.

Neuville A, Collin F, Bruneval P, Parrens M, Thivolet F, Gomez-Brouchet A, Terrier P, de Montpreville VT, Le Gall F, Hostein I, Lagarde P, Chibon F, Coindre JM.

Am J Surg Pathol. 2014 Apr;38(4):461-9. doi: 10.1097/PAS.0000000000000184.

PMID:
24625414
39.

Synthesis of full length and truncated microcin B17 analogues as DNA gyrase poisons.

Thompson RE, Collin F, Maxwell A, Jolliffe KA, Payne RJ.

Org Biomol Chem. 2014 Mar 14;12(10):1570-8. doi: 10.1039/c3ob42516a.

PMID:
24448886
40.

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

Isambert N, Ray-Coquard I, Italiano A, Rios M, Kerbrat P, Gauthier M, Blouet A, Chaigneau L, Duffaud F, Piperno-Neumann S, Kurtz JE, Girard N, Collard O, Bompas E, Penel N, Bay JO, Guillemet C, Collin F, Blay JY, Le Cesne A, Thariat J.

Eur J Cancer. 2014 Jan;50(1):128-36. doi: 10.1016/j.ejca.2013.09.012. Epub 2013 Oct 14.

PMID:
24135684
41.

The catalytically active copper-amyloid-Beta state: coordination site responsible for reactive oxygen species production.

Cassagnes LE, Hervé V, Nepveu F, Hureau C, Faller P, Collin F.

Angew Chem Int Ed Engl. 2013 Oct 11;52(42):11110-3. doi: 10.1002/anie.201305372. Epub 2013 Sep 3.

PMID:
24038998
42.

Mechanism of one-electron oxidation of metformin in aqueous solution.

Trouillas P, Marchetti C, Bonnefont-Rousselot D, Lazzaroni R, Jore D, Gardès-Albert M, Collin F.

Phys Chem Chem Phys. 2013 Jun 28;15(24):9871-8. doi: 10.1039/c3cp50602a.

PMID:
23673398
43.

Fragments of the bacterial toxin microcin B17 as gyrase poisons.

Collin F, Thompson RE, Jolliffe KA, Payne RJ, Maxwell A.

PLoS One. 2013 Apr 10;8(4):e61459. doi: 10.1371/journal.pone.0061459. Print 2013.

44.

Behavior of N-oxide derivatives in atmospheric pressure ionization mass spectrometry.

Ibrahim H, Couderc F, Perio P, Collin F, Nepveu F.

Rapid Commun Mass Spectrom. 2013 Mar 15;27(5):621-8. doi: 10.1002/rcm.6493.

PMID:
23413221
45.

Pt(II) compounds interplay with Cu(II) and Zn(II) coordination to the amyloid-β peptide has metal specific consequences on deleterious processes associated to Alzheimer's disease.

Collin F, Sasaki I, Eury H, Faller P, Hureau C.

Chem Commun (Camb). 2013 Mar 14;49(21):2130-2. doi: 10.1039/c3cc38537j. Epub 2013 Feb 5.

PMID:
23386213
46.

Copper and heme-mediated Abeta toxicity: redox chemistry, Abeta oxidations and anti-ROS compounds.

Chassaing S, Collin F, Dorlet P, Gout J, Hureau C, Faller P.

Curr Top Med Chem. 2012;12(22):2573-95. Review.

PMID:
23339309
47.

The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.

Karkare S, Chung TT, Collin F, Mitchenall LA, McKay AR, Greive SJ, Meyer JJ, Lall N, Maxwell A.

J Biol Chem. 2013 Feb 15;288(7):5149-56. doi: 10.1074/jbc.M112.419069. Epub 2012 Dec 28.

48.

[Changes in epithelioid soft tissue tumors].

Collin F.

Ann Pathol. 2012 Nov;32(5 Suppl):S111-4. doi: 10.1016/j.annpat.2012.07.005. Epub 2012 Oct 12. Review. French. No abstract available.

PMID:
23127925
49.

Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO).

Lindet C, Neuville A, Penel N, Lae M, Michels JJ, Trassard M, Terrier P, Birtwisle-Peyrottes I, Valo I, Collin F, Chateau MC, Robin YM, Coindre JM.

Eur J Cancer. 2013 Jan;49(2):369-76. doi: 10.1016/j.ejca.2012.08.016. Epub 2012 Sep 8.

PMID:
22967726
50.

Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).

Pautier P, Floquet A, Penel N, Piperno-Neumann S, Isambert N, Rey A, Bompas E, Cioffi A, Delcambre C, Cupissol D, Collin F, Blay JY, Jimenez M, Duffaud F.

Oncologist. 2012;17(9):1213-20. Epub 2012 Aug 20.

Supplemental Content

Loading ...
Support Center